These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3257165)

  • 21. Decreased intracellular compartmentalization of doxorubicin in cell lines expressing P-glycoprotein.
    Dordal MS; Jackson-Stone M; Ho AC; Winter JN; Atkinson AJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1286-90. PubMed ID: 7996436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatin phospholipids in normal and chronic lymphocytic leukemia lymphocytes.
    Manzoli FA; Maraldi NM; Cocco L; Capitani S; Facchini A
    Cancer Res; 1977 Mar; 37(3):843-9. PubMed ID: 300041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake of Lipiodol--cytotoxic conjugates by hepatoblastoma cells.
    Towu E; Al-Mufti R; Spitz L; Marron K; Winslet M
    Br J Surg; 2002 Apr; 89(4):437-41. PubMed ID: 11952584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The uptake of daunorubicin, adriamycin and aclarubicin into leukemic cells measured by flow cytometry].
    Arai N; Umeda M; Shirai T
    Gan To Kagaku Ryoho; 1990 May; 17(5):1077-9. PubMed ID: 2334174
    [No Abstract]   [Full Text] [Related]  

  • 25. Reactivity of cold agglutinins with subsets of human lymphocytes of various origins.
    Pruzanski W; Armstrong M; Ko H; Norman C; Minta J
    Haematologia (Budap); 1982 Dec; 15(4):409-18. PubMed ID: 6764629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cyclic adenosine monophosphate on the in vitro DNA synthesis in lymphocytes of patients with chronic lymphocytic leukemia.
    Konopka L; Karpowicz M; Rechowicz K; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):697-707. PubMed ID: 6260054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979).
    Callies S; de Alwis DP; Wright JG; Sandler A; Burgess M; Aarons L
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):107-18. PubMed ID: 12647011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r].
    Hu X; Chen WY
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):275-9. PubMed ID: 7976387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of flavonoid derivatives on doxorubicin transport and metabolism.
    Václavíková R; Kondrová E; Ehrlichová M; Boumendjel A; Kovár J; Stopka P; Soucek P; Gut I
    Bioorg Med Chem; 2008 Feb; 16(4):2034-42. PubMed ID: 18024139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
    Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative uptake and retention of adriamycin and N-benzyladriamycin-14-valerate in human CEM leukemic lymphocyte cell cultures.
    Israel M; Sweatman TW; Seshadri R; Koseki Y
    Cancer Chemother Pharmacol; 1989; 25(3):177-83. PubMed ID: 2598408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans.
    Mross K; Mayer U; Hamm K; Burk K; Hossfeld DK
    Eur J Clin Pharmacol; 1990; 39(5):507-13. PubMed ID: 2076745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate.
    Krishan A; Israel M; Modest EJ; Frei E
    Cancer Res; 1976 Jun; 36(6):2108-9. PubMed ID: 1268863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudan black B and peroxidase positivity in cultured lymphoid cells from patients with B-type chronic lymphocytic leukemia.
    Lanza F
    Haematologica; 1985; 70(5):458-9. PubMed ID: 3005143
    [No Abstract]   [Full Text] [Related]  

  • 37. Nuclear glucocorticoid binding in experimental and human leukemia.
    Stevens J; Stevens YW; Rhodes J; Sloan E; Rosenthal RL; Steiner G
    Mt Sinai J Med; 1979; 46(2):217-24. PubMed ID: 312451
    [No Abstract]   [Full Text] [Related]  

  • 38. Nuclear transport as an ultimate step of multidrug resistance.
    Bobichon H; Cailleret L; Ploton D; Belhoussine R; Jardillier JC
    Life Sci; 1999; 65(22):2343-9. PubMed ID: 10597889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoring.
    Siebel C; Lanvers-Kaminsky C; Würthwein G; Hempel G; Boos J
    Sci Rep; 2020 Oct; 10(1):18562. PubMed ID: 33122763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. gamma-Globulin metabolism in chronic lymphocytic leukemia.
    GOLDEN RL; MILLER DG; DIAMOND HD
    J Natl Cancer Inst; 1962 Sep; 29():443-53. PubMed ID: 13899731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.